Resources

Our community of economists and academic leaders from around the United States are united in their belief that more competition, innovation, accountability, consumer choice, and transparency are needed in America’s healthcare sector to improve the health and well-being of every patient.

The 340B Drug Discount Program Grew to $124B in 2023

May 10, 2024

IQVIA

By Rory Martin, PhD, and Harish Karne, MS

We Can’t Ignore Medicare’s Financial Woes

May 7, 2024

Paragon Health Institute

By Joe Albanese

The Relationship Between Biopharma R&D Investment and Expected Returns: Improving Evidence to Inform Policy

May 6, 2024

Information Technology & Innovation Foundation

By Kirsten Axelsen and Sandra Barbosu

Medicare Reform Initiative

May 1, 2024

Paragon Health Institute

Myths v. Facts Can Bayh-Dole March-In Rights Lower Drug Costs?

April 4, 2024

Bayh-Dole Coalition

Scroll to Top